IL95057A - Recombinant gene coding for a protein possessing urate oxidase activity - Google Patents

Recombinant gene coding for a protein possessing urate oxidase activity

Info

Publication number
IL95057A
IL95057A IL95057A IL9505790A IL95057A IL 95057 A IL95057 A IL 95057A IL 95057 A IL95057 A IL 95057A IL 9505790 A IL9505790 A IL 9505790A IL 95057 A IL95057 A IL 95057A
Authority
IL
Israel
Prior art keywords
oxidase activity
gene coding
urate oxidase
recombinant gene
protein possessing
Prior art date
Application number
IL95057A
Other languages
English (en)
Other versions
IL95057A0 (en
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elisabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL95057A0 publication Critical patent/IL95057A0/xx
Publication of IL95057A publication Critical patent/IL95057A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Glass Compositions (AREA)
IL95057A 1989-07-13 1990-07-12 Recombinant gene coding for a protein possessing urate oxidase activity IL95057A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.

Publications (2)

Publication Number Publication Date
IL95057A0 IL95057A0 (en) 1991-06-10
IL95057A true IL95057A (en) 1997-07-13

Family

ID=27251947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95057A IL95057A (en) 1989-07-13 1990-07-12 Recombinant gene coding for a protein possessing urate oxidase activity

Country Status (24)

Country Link
EP (1) EP0408461B1 (el)
JP (1) JP2664804B2 (el)
AT (1) ATE144282T1 (el)
AU (1) AU636637B2 (el)
BR (1) BR9006855A (el)
CA (1) CA2035900C (el)
DE (2) DE69028884T2 (el)
DK (1) DK0408461T3 (el)
ES (1) ES2095243T3 (el)
FI (1) FI105047B (el)
GR (1) GR3022085T3 (el)
HK (1) HK1000099A1 (el)
HU (1) HU215948B (el)
IE (1) IE77158B1 (el)
IL (1) IL95057A (el)
LU (1) LU90781I2 (el)
LV (1) LV12000B (el)
MC (1) MC2145A1 (el)
NL (1) NL300046I2 (el)
NO (1) NO2001018I2 (el)
NZ (1) NZ234453A (el)
PT (1) PT94680B (el)
RU (1) RU2105812C1 (el)
WO (1) WO1991000909A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (ja) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 ウリカーゼ遺伝子およびウリカーゼの製造法
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
CA2265464C (en) * 1996-09-13 2007-06-26 Transkaryotic Therapies, Inc. Therapy for .alpha.-galactosidase a deficiency
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CA2728907C (en) 1998-08-06 2015-11-24 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CA2419453C (en) 2000-08-17 2010-03-09 Ajinomoto Co., Inc. Mutant transglutaminase from streptoverticillium having modified substrate specificity
ES2367257T3 (es) 2002-04-25 2011-10-31 Shire Human Genetic Therapies, Inc. Tratamiento de deficit de alfa-galactosidasa a.
HU229626B1 (hu) 2005-04-11 2014-03-28 Savient Pharmaceuticals Urát oxidáz változat és alkalmazása
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
HU229068B1 (en) 2005-04-11 2013-07-29 Savient Pharmaceuticals Variant forms of urate oxidase and use thereof
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
KR101288027B1 (ko) 2006-04-12 2013-07-22 새비언트 파마수티컬즈 인크. 양이온 계면활성제를 이용한 단백질 정제 방법
RU2443426C2 (ru) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Конъюгаты уратоксидазы, фармацевтическая композиция для снижения уровней мочевой кислоты и способ получения вышеупомянутых конъюгатов
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529675A (fr) * 1967-03-29 1968-06-21 Applic Biochimiques Soc Et Urate oxydase à haute activité et sa préparation
SU457723A1 (ru) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Штамм 313-152 - продуцент уратоксидазы
CA1341130C (en) * 1984-07-27 2000-10-31 Adrianus Marinus Ledeboer Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (ja) * 1988-08-17 1994-09-14 サッポロビール株式会社 ウリカーゼのｄｎａ配列および製法

Also Published As

Publication number Publication date
EP0408461A1 (fr) 1991-01-16
AU636637B2 (en) 1993-05-06
ATE144282T1 (de) 1996-11-15
FI911212A0 (fi) 1991-03-12
IE902559A1 (en) 1991-02-27
HU215948B (hu) 1999-03-29
PT94680A (pt) 1991-04-18
DE10199042I1 (de) 2002-01-10
CA2035900C (fr) 2000-01-11
DE69028884T2 (de) 1997-05-07
RU2105812C1 (ru) 1998-02-27
FI105047B (fi) 2000-05-31
CA2035900A1 (fr) 1991-01-14
GR3022085T3 (en) 1997-03-31
LV12000B (lv) 1998-06-20
HU906046D0 (en) 1991-07-29
DE69028884D1 (de) 1996-11-21
BR9006855A (pt) 1991-08-06
HUT56884A (en) 1991-10-28
NL300046I2 (nl) 2001-12-01
LV12000A (lv) 1998-03-20
NO2001018I2 (no) 2006-05-01
ES2095243T3 (es) 1997-02-16
PT94680B (pt) 1997-04-30
LU90781I2 (fr) 2001-07-23
JPH04501807A (ja) 1992-04-02
WO1991000909A1 (fr) 1991-01-24
NZ234453A (en) 1993-01-27
NL300046I1 (nl) 2001-09-03
MC2145A1 (fr) 1992-02-18
IE77158B1 (en) 1997-12-03
DK0408461T3 (da) 1997-03-24
HK1000099A1 (en) 1997-11-21
IL95057A0 (en) 1991-06-10
EP0408461B1 (fr) 1996-10-16
AU6052390A (en) 1991-02-06
DE10199042I2 (de) 2003-10-23
JP2664804B2 (ja) 1997-10-22

Similar Documents

Publication Publication Date Title
IL95057A (en) Recombinant gene coding for a protein possessing urate oxidase activity
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
ES8704976A1 (es) Metodo pra la fabricacion de un polipeptido firiologicamente activo en el hombre.
AU3545684A (en) Independent suspension using c.v.j:s
KR0180256B1 (en) Bpc peptides, their preparation and use
DE69230535D1 (en) Polyphenol oxidase gene
EP0292220A3 (en) Condom
CA2014948A1 (en) Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
AU3979989A (en) Dna encoding human monoamine oxidase type a
IL76194A (en) 4,5-dihydro-4-oxo-2-((2-trans-phenyl cyclopropyl)amino)-3-furancarboxylic acids and derivatives
AU2280192A (en) Recombinant dna coding for a protein with endochitinase activity
AU6910991A (en) The scl gene, and the encoded hematopoietic factor
CA2066263A1 (en) Tsh receptor
AU2948189A (en) 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU1902088A (en) Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity
IL89241A (en) Recombinant vector comprising a dna segment encoding an enzyme having 2,5-diketogluconic acid(2,5-dkg)reductase activity
EP0549062A3 (el)
AU5627090A (en) A novel alpha-amylase-pullulanase enzyme, a dna sequence coding the same, a recombinant dna molecule and a recombinant clone expressing the enzyme
AU1072888A (en) 3-aryl-5-alkylthio-4H-1,2,4-thiazoles
AU6403590A (en) Isolated, physiologically active human thrombomodulin polypeptide
EP0659884A3 (en) Carrot 16kd protein, gene encoding this protein, and plazmid containing this gene.
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
BG102479A (en) Mew peptides, method for their preparation and application
AU643701B2 (en) 1-ethylphenoxathiin 10,10-dioxide
EP0222726A3 (en) Mutant coding sequence

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed